Scarica l'app Stockscreener
0.2824
0.46%
0.0013
Dopo l'orario di chiusura:
.28
-0.0024
-0.85%
Precedente Chiudi:
$0.2811
Aprire:
$0.2798
Volume 24 ore:
681.54K
Relative Volume:
1.07
Capitalizzazione di mercato:
$29.20M
Reddito:
$1.27M
Utile/perdita netta:
$-7.12M
Rapporto P/E:
-5.41
EPS:
-0.0522
Flusso di cassa netto:
$-5.28M
1 W Prestazione:
-0.91%
1M Prestazione:
-7.29%
6M Prestazione:
+7.79%
1 anno Prestazione:
-27.74%
Intervallo 1D:
$0.277
$0.29
Intervallo di 1 settimana:
$0.27
$0.29
Portata 52W:
$0.235
$0.4508
IGC Pharma Inc Stock (IGC) Company Profile
Nome
IGC Pharma Inc
Settore
Industria
Telefono
301-983-0998
Indirizzo
4336 Montgomery Avenue, Bethesda, MD
Compare IGC vs VRTX, REGN, MRNA, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.2824 | 29.20M | 1.27M | -7.12M | -5.28M | -0.0522 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
IGC Pharma Inc Borsa (IGC) Ultime notizie
PullBack Stocks PDSB, PRSO, IGC, RETO: Who Breaks First? - openPR.com
IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75." - ACCESS Newswire
IGC Pharma Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
IGC Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical-Stage Pipeline Stays in FocusWeak Earnings Momentum - careplusvn.com
IGC Pharma Evaluates Recovery After Left Verdict - ACCESS Newswire
Price to earnings forward of IGC Pharma, Inc. – AMEX:IGC - TradingView
IGC Pharma (NYSE: IGC) Target Raised on Alzheimer's 2027 Outlook - marketscreener.com
IGC Pharma (IGC) Slips to $0.31 as Key Support Comes into FocusMerger Arbitrage - dars.gov.et
Nasdaq 30's VIVS, IGC, RIME, AIXI Stocks Now - openPR.com
Nasdaq 30’s VIVS, IGC, RIME, AIXI Stocks Now - FinancialContent
IGC Q1 2026 Earnings: Narrower Loss Beats Estimates as Pipeline Progress Supports SentimentMargin Improvement Report - careplusvn.com
IGC (IGC) Technicals: Falls 0.65% to $0.31 on the Day; Level Watch: $0.29 and $0.33 Define the Nearby Reference Levels in the Latest ReadingLarge Cap Trends - vinanet.vn
MicroCaps IGC, BIVI, ORBS, RIME Sub-$1 Stocks to Watch Now - openPR.com
IGC Pharma earnings matched, revenue fell short of estimates By Investing.com - Investing.com India
IGC (IGC) Earnings Data Review: The Bottom-Line Figure Outpaces Its Comparison at the Close; Session Reaction: Shares Move 1.43% Higher in the Current UpdatePost-Earnings Reaction - vinanet.vn
IGC Pharma earnings matched, revenue fell short of estimates - Investing.com
IGC Pharma Releases Q2 2026 Financial Results - AlphaStreet
VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum - openPR.com
IGC Pharma execs buy 4.27M shares to settle $1.15M debt - scanx.trade
IGC Pharma Q2 Results: Sales up 39% YoY, EPS loss widens to $(0.03) - scanx.trade
IGC Looks 24.1% Overvalued on GF Value™ - GuruFocus
IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure - Finviz
IGC Pharma Q2 Results: CALMA Nears Enrollment Closure - accessnewswire.com
IGC Pharma, Inc. 2026: Revenue $265K, EPS ($0.03) — 10-Q Summary - TradingView
IGC Pharma (NYSE: IGC) widens loss while Phase 2 Alzheimer’s trial hits key milestone - Stock Titan
IGC Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Microcaps TOON, IGC, SURG, MDXH to Watch Now as Earnings, AI and Biotech Catalysts Build - openPR.com
IGC Pharma (NYSE American:IGC): What Does the Latest Update Mean for Clinical Development? - Kalkine Media
IGC Pharma Inc (IGC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IGC Pharma (NYSE AMERICAN:IGC): What Could Today’s regulatory execution Update Reveal? - Kalkine Media
IGC Pharma (NYSE AMERICAN:IGC): What Could Today’s cannabinoid research progress Update Reveal? - Kalkine Media
Early Alert: PLAG, PRSO, UZX, IGC Lead Sub-$1 Stocks to WatchPlus More in Focus - openPR.com
Early Alert: PLAG, PRSO, UZX, IGC Lead Sub-$1 Stocks to Watch – Plus More in Focus - FinancialContent
IGC Looks 21.6% Overvalued on GF Value™ - GuruFocus
IGC Pharma Advances CALMA Toward Q4 Topline Readout - ACCESS Newswire
IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer's Trial Approaches Enrollment Closure and Q4 Topline Readout - Corsicana Daily Sun
IGC Pharma Inc (IGS1.DU) balance sheet - Yahoo Finance UK
Enterprise value to revenue forward of IGC Pharma, Inc. – AMEX:IGC - TradingView
IGC Pharma Inc (IGC) Stock News Today - TradingKey
Price to sales forward of IGC Pharma, Inc. – MUN:IGS1 - TradingView
Bullish Volume: RITR, IGC, BJDX, CISS Lead Active Sub-$1 Stocks to Watch - openpr.com
IGC Q1 2026 Earnings: Narrower-Than-Expected Loss Marks 14.16% EPS BeatSaaS Earnings Trends - careplusvn.com
Microcaps MGRX, PRSO, IGC, KUST In the News to Watch - openPR.com
IGC Pharma, Inc. Revenue Breakdown – AMEX:IGC - TradingView
IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign - The Batesville Daily Guard
IGC|IGC Pharma Inc|Price:0.266|Chg%:+0.002 - TradingKey
IGC Pharma Hovers Near Support as Slight Decline Tests $0.26 LevelRounding Bottom - dars.gov.et
IGC|IGC Pharma Inc|Price:0.248|Chg%:-0.001 - TradingKey
IGC Pharma Inc (IGC) Cash Flow - TradingKey
IGC Pharma Inc (IGC) Balance Sheet - TradingKey
IGC Pharma Inc (IGC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IGC Pharma Inc Azioni (IGC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):